PVDF membranes were blocked in 5% non-fat dry milk in TTBS for 30–60 min. Primary antibodies were diluted in 5% non-fat dry milk in TTBS and the PVDF membrane was incubated at 4°C for 24–48 h. Secondary-HRP antibodies were also diluted in 5% non-fat dry milk in TTBS and the membrane was incubated for 1 h (hr) at RT. The membrane was submersed in
SuperSignal TM West Pico Plus Chemiluminescent Substrate (Thermo Fisher Scientific, 34577) following the manufacturer’s protocol and a
ChemidocTM MP imaging system (Bio-Rad) was used to develop the membranes.
Primary antibodies used include: mouse α-tubulin IgG1 (Sigma-Aldrich, T6199), mouse-myc IgG1 (Thermo Fisher, R950-25), mouse SOD2-A2 IgG2b (Santa Cruz, sc-133134), rabbit acetyl K68 SOD2 IgG (Abcam, ab137037), mouse anti-Poly-ADP-Ribose IgG3 (Trevigen, 4335-MC-100),
rabbit SIRT3 (Cell Signaling, D22A3), rabbit mAb androgen receptor (Cell Signaling, D6F11),
mouse ANTI-FLAG M2 (Sigma, F1804).
Secondary antibodies used include:
Goat anti-rabbit IgG-HRP (Invitrogen, 65–6120), Goat anti-mouse IgG1-HRP (Invitrogen, A10551), Goat anti-mouse IgG2B-HRP (Novus, P33), Goat anti-mouse IgG3-HRP (Invitrogen, M32607)
Garcia Castro D.R., Mazuk J.R., Heine E.M., Simpson D., Pinches R.S., Lozzi C., Hoffman K., Morrin P., Mathis D., Lebedev M.V., Nissley E., Han K.H., Farmer T., Merry D.E., Tong Q., Pennuto M, & Montie H.L. (2023). Increased SIRT3 combined with PARP inhibition rescues motor function of SBMA mice. iScience, 26(8), 107375.